Article Details

Entasis Therapeutics (NASDAQ:ETTX) Stock Rating Lowered by ValuEngine

Retrieved on: 2019-01-20 18:46:46

Tags for this article:

Click the tags to see associated articles and topics

Entasis Therapeutics (NASDAQ:ETTX) Stock Rating Lowered by ValuEngine. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new stake in shares of Entasis Therapeutics in the third quarter valued at $12,840,000. Luminus Management LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up